There were certainly some surprises this last month in the Port24. I had sold covered calls against CLDX, ONTY, NBIX, DCTH, and MITI.
All expired harmlessly except for ONTY - it has been rising sharply and were exercised a good 25% above my $4 strike. It hurts to lose the extra amount I might have made, except for two things:
1) would I have actually sold at this price, or would I have sold earlier, or waited and had it go down again?
2) I bought these about a year ago with an average price of $3.46, and sold $0.70 cents of premium along the way... so my net return here has been around 35%.
CLDX just did a secondary offering which knocked it down from exercisable range to the present price. I expect it to be nudging $4 again within a couple months.
NBIX has dropped recently but with Phase 3 trials starting late summer, it should be climbing nicely over the next few months.
Celsion (CLSN) enrollment in the HEAT trial continues to be something I look forward to, over the next two months. They should have hit the 190th PFS event easily by this time and so we'll get to know the results of an interim calculation by the end of Q3 at the latest.
The Port has an annualized return of 17.1% with just over three years. That compares nicely to the S&P being flat over the same period and the Nasdaq gain of 7%.
With ONTY being exercised, I have $28,913.35 in cash and the following holdings:
Shares (calls sold)
2600 CLDX (0)
1200 BTX (0)
2000 NBIX (0)
7000 NNVC (0)
1600 DCTH (0)
3600 PZG (0)
9000 CLSN (0)
2000 MITI (0)
800 SGEN (8)
1600 SGMO (0)
Showing posts with label Nanoviricides. Show all posts
Showing posts with label Nanoviricides. Show all posts
Sunday, May 22, 2011
Thursday, April 7, 2011
More covered calls & Port24 update
Seeing as how option expiration is next week, I decided to get some premium this morning. DNDN Apr $40s for $0.38, DCTH May $9s for $0.50, and SGEN Jun $17.50 for $0.85. Nanoviricides (NNVC) is having a good week, up the $1.50s on more FluCide news. I actually sold a little in my real money portfolios, as I try to trade this one more actively than I sometimes do (this is in an IRA so I don't have to worry about taxes). If you have a 2 to 5 year holding time, this is still not a bad time to buy but I suspect it will be 10 to 20 cents lower in a month or two. The Port24 is back over 20% annualized returns... Dendreon's return to the high $30s as well as Nanoviricide's pop contributed. Celsion has been lagging but I expect within three months it will be the star of the show. I am loaded in CLSN in my real money accounts as well. Cash = $3,390.35 2600 CLDX (26) 400 DNDN (4) 2000 NBIX (20) 7000 NNVC (0) 7000 ONTY (70) 1600 DCTH (16) 3600 PZG (0) 9000 CLSN (0) 2000 MITI (0) 800 SGEN (8) Regards, Trond
Labels:
Celsion,
Covered calls,
Delcath,
Dendreon,
Nanoviricides,
Port24,
Seattle Genetics
Sunday, April 3, 2011
Another covered call sale
On Friday I sold 20 NBIX calls - the May $8s - for $0.25 in the Port. That brings us up to a 16.5% annual return and rapidly closing in on three years of the Port24. I have the holdings listed below. Of them all, the only ones I would consider buys right now are Celsion, Nanoviricides, and Paramount Gold. I would expect PZG to release their first resource report this coming week, and will probably sell out of the Port when that occurs. I have quite a few shares of PZG in my real-money accounts, however, and will only sell modestly there... I think 2011 will be a great year for PZG. Nanoviricides may not have any news for months but then again it may announce something any time. I wouldn't add massively today, but to start a position it's a great time in the $1.20s. Celsion also may not move for a couple months but it really is time to fish or cut bait here. By May or June it will have started its runup, and I expect to have a double from here by the end of June. Regards, Trond Port24 holdings (calls against) 2600 CLDX (26) 400 DNDN (0) 2000 NBIX (20) 7000 NNVC (0) 7000 ONTY (70) 1600 DCTH (0) 3600 PZG () 9000 CLSN (0) 2000 MITI (0) 800 SGEN (0) $1,814.37 cash
Labels:
Celsion,
Covered calls,
Nanoviricides,
Neurocrine,
Paramount Gold,
Port24
Tuesday, February 8, 2011
Port 24 update and new buys (Celsion)
Let's attend to the Port24 first... some activity today. I had $28K available and did not want to stall on my recent gains.
CLDA got approval and is at the $30 mark. I chose to keep the shares and sell Feb $35 calls for $1. I also sold Feb $7.50 calls on NBIX for $0.20 - the stock itself is at $7.50 right now.
Finally, I sold ONTY May $4 calls since it will be awhile since we get any news. With the stock at $3.06, it gives a 1% per month "dividend" while still allowing the sale at $4 if we do get any bonus news.
I bought 5000 shares of CLSN and 2000 shares of MITI. I have not yet sold calls since I think each will move upwards short term and allow better premium or better strikes than exist right now.
The Port now stands at $146,634.38, with $4,064.38 in cash and the positions and (calls) shown below-- a 46% overall gain and a 17% annualized gain. This compares, over the same period, to a -0.5% annualized gain in the S&P (SPY) and a 7.1% gain in the Nasdaq (QQQQ).
2600 CLDX (26)
600 CLDA (6)
400 DNDN
2000 NBIX (10)
7000 NNVC
7000 ONTY (70)
1000 DCTH (10)
600 DCTH
3600 PZG
5000 CLSN
2000 MITI
Real money wise, I have been buying CLSN hand over fist. They should have news this week of Japan restarting enrollment in the HEAT trial, after a planned halt and safety review.
Nanoviricides (NNVC) also gets some new cash, as they are involved in a dengue conference next week.
DCTH should get formal acceptance of their NDA very soon. I am holding this in real accounts as well, and will sell shorter term calls once it gets a spike around $12.
Regards,
Trond
CLDA got approval and is at the $30 mark. I chose to keep the shares and sell Feb $35 calls for $1. I also sold Feb $7.50 calls on NBIX for $0.20 - the stock itself is at $7.50 right now.
Finally, I sold ONTY May $4 calls since it will be awhile since we get any news. With the stock at $3.06, it gives a 1% per month "dividend" while still allowing the sale at $4 if we do get any bonus news.
I bought 5000 shares of CLSN and 2000 shares of MITI. I have not yet sold calls since I think each will move upwards short term and allow better premium or better strikes than exist right now.
The Port now stands at $146,634.38, with $4,064.38 in cash and the positions and (calls) shown below-- a 46% overall gain and a 17% annualized gain. This compares, over the same period, to a -0.5% annualized gain in the S&P (SPY) and a 7.1% gain in the Nasdaq (QQQQ).
2600 CLDX (26)
600 CLDA (6)
400 DNDN
2000 NBIX (10)
7000 NNVC
7000 ONTY (70)
1000 DCTH (10)
600 DCTH
3600 PZG
5000 CLSN
2000 MITI
Real money wise, I have been buying CLSN hand over fist. They should have news this week of Japan restarting enrollment in the HEAT trial, after a planned halt and safety review.
Nanoviricides (NNVC) also gets some new cash, as they are involved in a dengue conference next week.
DCTH should get formal acceptance of their NDA very soon. I am holding this in real accounts as well, and will sell shorter term calls once it gets a spike around $12.
Regards,
Trond
Labels:
Celsion,
Delcath,
Nanoviricides,
Paramount Gold,
Port24
Subscribe to:
Posts (Atom)